Burgess Julie 4
4 · Design Therapeutics, Inc. · Filed Oct 4, 2021
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2021-10-01+135,000→ 135,000 totalExercise: $14.99Exp: 2031-09-30→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest one year after September 13, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.